{
    "organizations": [],
    "uuid": "9f0e5fc67d4b911dfdcbd854bb0c470ef260d2d5",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-us-fda-authorizes-first-test-to-id/brief-u-s-fda-authorizes-first-test-to-identify-emerging-pathogen-candida-auris-idUSFWN1RX0ZI",
    "ord_in_thread": 0,
    "title": "BRIEF-U.S FDA Authorizes First Test To Identify Emerging Pathogen Candida Auris",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 20 (Reuters) - U.S. Food and Drug Administration:\n* U.S FDA SAYS AUTHORIZED FIRST TEST TO IDENTIFY EMERGING PATHOGEN CANDIDA AURIS\n* U.S. FDA SAYS PERMITTED MARKETING FOR A NEW USE OF THE BRUKER MALDI BIOTYPER CA SYSTEM FOR THE IDENTIFICATION OF CANDIDA AURIS\n* U.S. FDA SAYS FDA GRANTED MARKETING AUTHORIZATION OF THE TEST TO IDENTIFY CANDIDA AURIS TO BRUKER DALTONIK GMBH Source text: ( bit.ly/2F27D1B )\n ",
    "published": "2018-04-21T03:54:00.000+03:00",
    "crawled": "2018-04-21T18:23:47.006+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "food",
        "drug",
        "administration",
        "fda",
        "say",
        "authorized",
        "first",
        "test",
        "identify",
        "emerging",
        "pathogen",
        "candida",
        "auris",
        "fda",
        "say",
        "permitted",
        "marketing",
        "new",
        "use",
        "bruker",
        "maldi",
        "biotyper",
        "ca",
        "system",
        "identification",
        "candida",
        "auris",
        "fda",
        "say",
        "fda",
        "granted",
        "marketing",
        "authorization",
        "test",
        "identify",
        "candida",
        "auris",
        "bruker",
        "daltonik",
        "gmbh",
        "source",
        "text"
    ]
}